CANCER FUND
Prashanth Kini is a seasoned professional in the venture capital and healthcare technology sectors, currently serving as a Venture Partner at CANCER FUND since July 2023. At Astute Imaging, Kini holds roles as both an Investor and Advisor, focusing on AI solutions for image-guided therapy. In addition to leadership at AcumedAI LLC as Principal, Kini is an Investor with the Biosciences Special Purpose Vehicle and Volo Ventures, and has a long-standing involvement with Oakhouse Partners in early-stage enterprise software investments. Previous experience includes advisory and executive roles at Mainstream Genomics, SAIGroup, SymphonyAI, and Ayasdi, where notable contributions involved AI-driven healthcare innovations. Prashanth Kini holds a PhD and BSEE in Electrical and Computer Engineering from the University of Cincinnati.
CANCER FUND
CANCER FUND is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at www.cancerfund.com.